1-4 of 4
Sisi Zhen
Close
Sort by
Journal Articles

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng
Journal: Blood
Blood (2023) 142 (Supplement 1): 7094.
https://doi.org/10.1182/blood-2023-190923
Published: 2023
Journal Articles

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis

Yuyan Shen, Tingting Zhang, Zhangjie Chen, Sisi Zhen, Jieru Wang, Erlie Jiang, Xudong Liao, Sizhou Feng
Journal: Blood
Blood (2023) 142 (Supplement 1): 4798.
https://doi.org/10.1182/blood-2023-185874
Published: 2023
Journal Articles

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Sisi Zhen, Qingsong Lin, Weihua Zhai, Erlie Jiang, Sizhou Feng
Journal: Blood
Blood (2023) 142 (Supplement 1): 5363.
https://doi.org/10.1182/blood-2023-188815
Published: 2023
Journal Articles

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study

Jieru Wang, Sisi Zhen, Erlie Jiang, Sizhou Feng
Journal: Blood
Blood (2023) 142 (Supplement 1): 2163.
https://doi.org/10.1182/blood-2023-189152
Published: 2023